logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

Wenrong Huang

Chinese People's Liberation Army General Hospital
H指数:22
被引数:1,485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Favorable impact of zanubrutinib combined with R-CHOP regimen in MYD88-mutated new-diagnosed diffuse large B-cell lymphoma: a retrospective study with propensity score-matched analysis

zanubrutinib联合R-CHOP方案对MYD88突变型新诊断弥漫性大B细胞淋巴瘤的有利影响：一项倾向性评分匹配分析回顾性研究

cancer immunology immunotherapy
IF0
2025-07-050
OAAI
Xiubin Xiao; Shunzong Yuan; Xilin Chen; Xia Liu; Ruiqing Zhao; Shihua Zhao; Yun Lu; Yi Ma; Junli Chen; Yueqi Wang; Nana Cheng; Hua Yin; Honghao Gao; Pan Feng; Wenrong Huang
Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study

以Ixazomib为基础的一线治疗，随后在新诊断为多发性骨髓瘤的虚弱老年患者中进行ixazomib维持治疗: 一项前瞻性多中心研究

ECLINICALMEDICINE
IF10
2024-02-011
OAAI
Bao, Li; Wang, Yu -Tong; Liu, Peng; Lu, Min-Qiu; Zhuang, Jun -Ling; Zhang, Mei; Xia, Zhong-Jun; Li, Zhen-Ling; Yang, Ying; Yan, Zhen-Yu; Jing, Hong-Mei; Dong, Fei; Chen, Wen -Ming; Wu, Yin; Zhou, He -Bing; Fu, Rong; Gong, Yu -Ping; Huang, Wen-Rong; Zhang, Yong-Qing
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment
BLOOD ADVANCES
IF7.1
2023-12-152
OAAI
Jian, Yuan; Chang, Long; Shi, Ming-Xia; Sun, Ying; Chu, Xiao-Xia; Xue, Hua; Huang, Wen-Rong; Shen, Xu-Liang; Ma, Jie; Jia, Guo-Rong; Feng, Ya-Qing; Xi, Zhen-Fang; Zhao, Yan-Hong; Ma, Yan-Ping; Xiao, Jing; Ma, Guang-Yu; Wang, Qing-Ming; Bao, Li; Dong, Yu-Jun; Zhou, He-Bing; Sun, Chun-Yan; Su, Guo-Hong; Yan, Yan; Qimuge, Sai-Yin; Su, Li-Ping; Sun, Jing-Nan; Tian, Wei-Wei; Sun, Xiu-Li; Ing, Hong-Mei; Gao, Da; Chen, Wen-Ming; Li, Jian; Gao, Wen
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study

自体造血干细胞移植改善外周T细胞淋巴瘤的生存结局: 一项多中心回顾性真实世界研究

ANNALS OF HEMATOLOGY
IF2.4
2023-09-121
OAAI
Wu, Meng; Wang, Fengrong; Zhao, Shihua; Li, Yajun; Huang, Wenrong; Nie, Bo; Liu, Haisheng; Liu, Xiaoqian; Li, Wei; Yu, Haifeng; Yi, Kun; Dong, Fei; Dong, Yujun; Yuan, Chenglu; Ran, Xuehong; Xiao, Xiubin; Liu, Weiping; Zhu, Jun
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study

奥列拉布替尼治疗复发或难治性边缘区淋巴瘤: 2期、多中心、开放标签研究

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2023-08-302
PRE
Deng, Lijuan; Li, Zhiming; Zhang, Huilai; Huang, Haiwen; Hu, Jianda; Liu, Lihong; Liu, Ting; Jin, Jie; Zhu, Zunmin; Li, Wenyu; Huang, Zhenqian; Huang, Wenrong; Zhou, Keshu; Yang, Haiyan; Zhang, Mingzhi; Ding, Kaiyang; Zhou, Hui; Hu, Yu; Shuang, Yuerong; Cao, Junning; Gao, Sujun; Li, Dengju; Sun, Zimin; Zhang, Qingyuan; Yi, Shuhua; Ji, Chunyan; Zhang, Liansheng; Hou, Cheng; Du, Yue; Wang, Weige; Zhao, Renbin; Song, Yuqin; Zhu, Jun
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria
LANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
2023-05-014
OAAI
Zhang, Lu; Dong, Yu-jun; Peng, Hong-ling; Li, Hao; Zhang, Ming-Zhi; Wang, Hui-han; Liu, Qin-hua; Su, Li-ping; Zhong, Li-ye; Wu, Wen-jun; Huang, Liang; Yan, Xiao-jing; Fan, Lei; Tang, Wen-jiao; Li, Zhen-ling; Bi, Lin-tao; Li, Yan; Gao, Guang-xun; Gao, Li; Liu, Ting-bo; Wei, Yong-qiang; Liu, Yao; Yu, Li; Zhou, Hui; Sun, Chun-yan; Qian, Wen-bin; Zou, De-hui; Zhang, Hui-lai; Ding, Kai-yang; Wang, Xiao-bo; Bai, Ou; Huang, Wen-rong; Chen, Bing; Yang, Lin; Song, Jia; Gao, Da; Chen, Tong; Luo, Jun; Wang, Shu-ye; Ma, Liang-ming; Fajgenbaum, David C.; Li, Jian
Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies

血液系统恶性肿瘤患者单倍体相合同和匹配同胞PBSCT后爱泼斯坦-巴尔病毒dna血症和移植后淋巴增生性疾病的危险因素和临床结局

ANNALS OF HEMATOLOGY
IF2.4
2019-06-2632
PREAI
Gao, Xiao-Ning; Lin, Ji; Wang, Li-Jun; Li, Fei; Li, Hong-Hua; Wang, Shu-Hong; Huang, Wen-Rong; Gao, Chun-Ji; Yu, Li; Liu, Dai-Hong

研究方向

暂未获取到该数据
D
Dai‐Hong Liu
H 指数:41论文数:393被引数:7,079
于
于力
H 指数:56论文数:686被引数:1.3万
S
Shuhong Wang
H 指数:20论文数:108被引数:1,309
L
Liping Dou
H 指数:20论文数:197被引数:1,539
高晓宁 封面图
高晓宁
H 指数:19论文数:103被引数:1,356
Y
Yujun Dong
H 指数:17论文数:226被引数:1,034
李
李飞
H 指数:27论文数:348被引数:2,652
H
Honghua Li
H 指数:27论文数:208被引数:2,615
C
Chunji Gao
H 指数:18论文数:131被引数:1,268
J
Ji Lin
H 指数:19论文数:44被引数:1,413